Fortress Biotech, Inc. (FBIO) Share-based Payment Arrangement, Expense USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fortress Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Fortress Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.86 M, a 2.66% increase year-over-year.
  • Fortress Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $17.2 M, a 22.6% decline year-over-year.
  • Fortress Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17 M, a 25.9% decline from 2022.
  • Fortress Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $23 M, a 18% increase from 2021.
  • Fortress Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $19.5 M, a 44.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $17.2 M $4.86 M +$126 K +2.66% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $17 M $3.7 M -$1.8 M -32.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $18.8 M $4.38 M -$2.46 M -36% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $21.3 M $4.22 M -$864 K -17% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $22.2 M $4.73 M -$832 K -15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $23 M $5.51 M -$1.53 M -21.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $24.5 M $6.84 M +$2.51 M +58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $22 M $5.08 M +$731 K +16.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $21.3 M $5.56 M +$1.79 M +47.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $19.5 M $7.04 M +$3.91 M +125% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $15.6 M $4.33 M +$1.16 M +36.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $14.4 M $4.35 M +$602 K +16.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $13.8 M $3.77 M +$373 K +11% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $13.5 M $3.13 M +$367 K +13.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $13.1 M $3.17 M -$570 K -15.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $13.7 M $3.75 M +$375 K +11.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $13.3 M $3.4 M +$91 K +2.75% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $13.2 M $2.77 M Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $3.74 M -$365 K -8.89% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $3.37 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3.31 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 $4.11 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q1 2016 $1.1 M -$1.9 M -63.3% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q1 2015 $3 M Jan 1, 2015 Mar 31, 2015 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.